Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity
TM
tristan manalac
via Biospace
Updated 1h ago
Source Verification
Corroboration Score: 1This story was independently reported by 1 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...
Previous
Sophie Turner back injury shuts down filming on Lara Croft reboot
Next
Managed wetlands a culinary hot spot for SF bay fish, but they need delivery options
Related Articles
Health254876 ANDRES DIAZ-DIAZ
Reflector-13h ago-1 sources
HealthDunn County Human Services talks challenges, importance during National Social Work Month
Gazette Xtra-13h ago-1 sources
HealthIDF Suspends Israeli Reserve Soldiers Who Detained and Assaulted CNN Crew Covering West Bank Confrontation
Thewrap-13h ago-1 sources